You are here
- Home
- drug reactions
drug reactions
- Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitisAndrea Davis Puente, Douglas B Johnson, Julie A BastaracheBMJ Open Respiratory Research Apr 2023, 10 (1) e001342; DOI: 10.1136/bmjresp-2022-001342
- Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitorsLei Zhang, John Coffin, Kim Formenti, Quincy Chu, Iyare IzevbayeBMJ Open Respiratory Research Jan 2022, 9 (1) e001154; DOI: 10.1136/bmjresp-2021-001154
- Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic reviewRoshni Patel, Sumrah A Naqvi, Chris Griffiths, Chloe I BloomBMJ Open Respiratory Research Dec 2020, 7 (1) e000756; DOI: 10.1136/bmjresp-2020-000756
- Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependenceChristopher N Schmickl, Robert L Owens, Jeremy E Orr, Bradley A Edwards, Atul MalhotraBMJ Open Respiratory Research Apr 2020, 7 (1) e000557; DOI: 10.1136/bmjresp-2020-000557
- Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort studySirak Tesfamariam, Amon Solomon Ghebrenegus, Henok Woldu, Ephrem Fisseha, Gebremeskel Belai, Mulugeta RussomBMJ Open Respiratory Research Nov 2021, 8 (1) e001064; DOI: 10.1136/bmjresp-2021-001064
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)